Simulating the impact of a molecular 'decision-process' on cellular phenotype and multicellular patterns in brain tumors

Harvard University, Cambridge, Massachusetts, United States
Journal of Theoretical Biology (Impact Factor: 2.12). 05/2005; 233(4):469-81. DOI: 10.1016/j.jtbi.2004.10.019
Source: PubMed


Experimental evidence indicates that human brain cancer cells proliferate or migrate, yet do not display both phenotypes at the same time. Here, we present a novel computational model simulating this cellular decision-process leading up to either phenotype based on a molecular interaction network of genes and proteins. The model's regulatory network consists of the epidermal growth factor receptor (EGFR), its ligand transforming growth factor-alpha (TGF alpha), the downstream enzyme phospholipaseC-gamma (PLC gamma) and a mitosis-associated response pathway. This network is activated by autocrine TGF alpha secretion, and the EGFR-dependent downstream signaling this step triggers, as well as modulated by an extrinsic nutritive glucose gradient. Employing a framework of mass action kinetics within a multiscale agent-based environment, we analyse both the emergent multicellular behavior of tumor growth and the single-cell molecular profiles that change over time and space. Our results show that one can indeed simulate the dichotomy between cell migration and proliferation based solely on an EGFR decision network. It turns out that these behavioral decisions on the single cell level impact the spatial dynamics of the entire cancerous system. Furthermore, the simulation results yield intriguing experimentally testable hypotheses also on the sub-cellular level such as spatial cytosolic polarization of PLC gamma towards an extrinsic chemotactic gradient. Implications of these results for future works, both on the modeling and experimental side are discussed.

Download full-text


Available from: Chaitanya Athale
  • Source
    • "A variety of modeling strategies are available to investigate one or more aspects of cancer. Discrete cell-based models (e.g., cellular automata [2] [9] [30] [44] [46] [62] and agent-based models [7] [43] [50]), where individual cells are tracked and updated according to a specific set of biophysical rules, are particularly useful for studying carcinogenesis, natural selection, genetic instability, and interactions of individual cells with each other and the microenvironment . In larger-scale systems, continuum methods provide a good modeling alternative [14] [16] [17] [18] [19] [27] [37] [39] [48]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In this paper, we reformulate the diffuse interface model of the tumor growth (S.M. Wise et al., Three-dimensional multispecies nonlinear tumor growth-I: model and numerical method, J. Theor. Biol. 253 (2008) 524{543). In the new proposed model, we use the conservative second-order Allen{Cahn equation with a space{time dependent Lagrange multiplier instead of using the fourth-order Cahn{Hilliard equation in the original model. To numerically solve the new model, we apply a recently developed hybrid numerical method. We perform various numerical experiments. The computational results demonstrate that the new model is not only fast but also has a good feature such as distributing excess mass from the inside of tumor to its boundary regions.
    Full-text · Article · Aug 2015 · Mathematical Biosciences and Engineering
  • Source
    • "In the case of cancer modelling, a few multiscale approaches exist [31]. In [32] [33], a model for glioblastoma growth was introduced that combines an agent based model with an EGFR (epidermal growth factor receptor) signalling network and focuses on the determination of the cell phenotypes " migrating " and " proliferating. " Later, also a model for the progression of lung cancer was developed [34] in that essentially only the molecular interaction network was interchanged. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Glioblastomas are highly malignant brain tumours. Mathematical models and their analysis provide a tool to support the understanding of the development of these tumours as well as the design of more effective treatment strategies. We have previously developed a multiscale model of glioblastoma progression that covers processes on the cellular and molecular scale. Here, we present a novel nutrient-dependent multiscale sensitivity analysis of this model that helps to identify those reaction parameters of the molecular interaction network that influence the tumour progression on the cellular scale the most. In particular, those parameters are identified that essentially determine tumour expansion and could be therefore used as potential therapy targets. As indicators for the success of a potential therapy target, a deceleration of the tumour expansion and a reduction of the tumour volume are employed. From the results, it can be concluded that no single parameter variation results in a less aggressive tumour. However, it can be shown that a few combined perturbations of two systematically selected parameters cause a slow-down of the tumour expansion velocity accompanied with a decrease of the tumour volume. Those parameters are primarily linked to the reactions that involve the microRNA-451 and the thereof regulated protein MO25.
    Full-text · Article · May 2014 · Computational and Mathematical Methods in Medicine
  • Source
    • "The EGFR has been implicated in several cancers including lung cancer, breast cancer, and glioblastoma, yet the EGFR activity itself is not capable of predicting the phenotype of cancer cells. As shown in Fig. 2 (top box), a microscopic, EGFR gene-protein interaction network-based model has been developed [25]. Given initial concentrations of important molecules in tumor microenvironment such as glucose, oxygen, and transforming growth factor α (TGFα), the model predicts whether the cell proceeds to proliferation or migration. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Significant Virtual Physiological Human (VPH) efforts and projects have been concerned with cancer modeling, especially in the European Commission Seventh Framework research programme, with the ambitious goal to approach personalized cancer simulation based on patient-specific data and thereby optimize therapy decisions in the clinical setting. However, building realistic in silico predictive models targeting the clinical practice requires interactive, synergetic approaches to integrate the currently fragmented efforts emanating from the systems biology and computational oncology communities all around the globe. To further this goal we propose an intelligent graphical workflow planning system that exploits the multiscale and modular nature of cancer and allows building complex cancer models by intuitively linking/interchanging highly specialized models. The system adopts and extends current standardization efforts, key tools and infrastructure in view of building a pool of reliable and reproducible models capable of improving current therapies and demonstrating the potential for clinical translation of these technologies.
    Full-text · Article · Jan 2014 · IEEE Journal of Biomedical and Health Informatics
Show more